Connection

Yuki Kageyama to Dexamethasone

This is a "connection" page, showing publications Yuki Kageyama has written about Dexamethasone.
Connection Strength

0.215
  1. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6012-7.
    View in: PubMed
    Score: 0.061
  2. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res. 2006 May 15; 12(10):3003-9.
    View in: PubMed
    Score: 0.059
  3. Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. J Med Case Rep. 2018 May 30; 12(1):151.
    View in: PubMed
    Score: 0.034
  4. Central nervous system mediates an antihypertensive property in glucocorticoid hypertension in dogs. J Hypertens. 1995 Oct; 13(10):1169-79.
    View in: PubMed
    Score: 0.028
  5. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hypertens. 1994 Nov; 16(6):761-78.
    View in: PubMed
    Score: 0.027
  6. Depressor systems contribute to hypertension induced by glucocorticoid excess in dogs. J Hypertens. 1992 Jun; 10(6):561-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.